Thursday, October 06, 2016 7:17:04 AM
The delay in Europe right now might be due to regulatory red tape in the various counties: Ethics approval, data collection approval etc. I do think Clinuvel might regret by now that they decided to go it alone without a partner. Simply, they are too inexperienced to do a roll out by themselves. But it's learning by doing and eventually they will get it right and, as you say, perhaps use that experience to roll out Scenesse in the US for EPP while partnering for Vitiligo.
As for communication: It's a total disaster.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM